Expert Perspectives 2026
Cell and Gene Therapy at a Turning Point
Welcome to our video library presenting the recorded sessions from our scientific symposium, “Cell and Gene Therapy at a Turning Point” held in November 2026 in Cologne. Bringing together leading experts, the event showcased pioneering research, strategic perspectives, and practical insights. This curated collection offers a comprehensive and forward-looking view of the opportunities and challenges shaping the field of cell and gene therapy.
Dr. Jens Altrichter
Artcline
Rethinking Sepsis: The Potential of Allogeneic Immune-Cell Therapy Opportunities and Challenges
Dr. Matthias Domogalla
Cellex Cell Professionals
Turning Quality into Performance: Using GMP Compliance to Optimize Cell Therapy Manufacturing
Ali Mohamed, Ph.D.
Immatics Biotechnologies
Translating PRAME Targeting into TCR-T Cell Product Development
and Manufacturing
Prof. Dr. med. Martin Wermke
Dresden University of Technology
Addressing Difficult to Target Antigens in Solid Tumors and
Hematologic Malignancies in the Clinic
Dr. Suvi Annala
Cellex Cell Professionals
One Partner, Every Scale: An Integrated CDMO Perspective on
Commercialization
Dr. Hyatt Balke-Want
University Hospital Cologne
From Code to Cure:
Genome Engineering in T Cells
Prof. Dr. med. Elke Jäger
North-West Hospital Frankfurt
Harnessing Tumor-Specific T Cells and Peptide Vaccines for Cancer
Immunotherapy
Ping Shek
STBIO
China’s Biotech Industry
in the Global Context